Authors: Hink, U Li, HG Mollnau, H Oelze, M Matheis, E Hartmann, M Skatchkov, M Thaiss, F Stahl, RAK Warnholtz, A Meinertz, T Griendling, K Harrison, DG Forstermann, U Munzel, T

Citation: U. Hink et al., Mechanisms underlying endothelial dysfunction in diabetes mellitus, CIRCUL RES, 88(2), 2001, pp. E14-E22

Authors: Mulsch, A Oelze, M Kloss, S Mollnau, H Topfer, A Smolenski, A Walter, U Stasch, JP Warnholtz, A Hink, U Meinertz, T Munzel, T

Citation: A. Mulsch et al., Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta, CIRCULATION, 103(17), 2001, pp. 2188-2194

Authors: Munzel, T Mollnau, H Hartmann, M Geiger, C Oelze, M Warnholtz, A Yehia, AH Forstermann, U Meinertz, T

Citation: T. Munzel et al., Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production, J AM COL C, 36(2), 2000, pp. 628-634

Authors: Oelze, M Mollnau, H Hoffmann, N Warnholtz, A Bodenschatz, M Smolenski, A Walter, U Skatchkov, M Meinertz, T Munzel, T

Citation: M. Oelze et al., Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction, CIRCUL RES, 87(11), 2000, pp. 999-1005

Authors: Munzel, T Li, H Mollnau, H Hink, U Matheis, E Hartmann, M Oelze, M Skatchkov, M Warnholtz, A Duncker, L Meinertz, T Forstermann, U

Citation: T. Munzel et al., Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-Mediated superoxide production, and vascular NO bioavailability, CIRCUL RES, 86(1), 2000, pp. E7-E12

Authors: Kleschyov, AL Mollnau, H Oelze, M Meinertz, T Huang, Y Harrison, DG Munzel, T

Citation: Al. Kleschyov et al., Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate, BIOC BIOP R, 275(2), 2000, pp. 672-677